The University Medical Center Hamburg-Eppendorf is the teaching hospital of the University of Hamburg and one of the largest hospitals in Hamburg, Germany. The UKE has 1,460 beds and 121 day-care places and is listed to provide the capacity to dispatch emergency medical services.

There are 1,460 beds in Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf.

During the past decade, Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "BRAHMS GmbH" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Biosyn" with 1 trials as a collaborator and "Brahms AG" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf" are "Septic Shock" (3 trials), "Respiratory Failure" (2 trials), "Severe Sepsis" (2 trials) and "Value of Virtual Autopsy for Quality Control in Icu" (1 trials). Many other conditions were trialed in "Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf" in a lesser frequency.

Most popular intervention types in "Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf" are "Device" (3 trials), "Procedure" (3 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Cytosorb® 300 ml" (1 trials), "High flow nasal cannula oxygen" (1 trials), "Intubation" (1 trials), "Nose-mouth mask" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".